Holdings of the Fund as of 7/16/2024
Total Number of Holdings (excluding cash): 50
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
1,207 |
$87,072.98 |
2.85% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
3,103 |
$80,381.23 |
2.63% |
| Hoya Corporation |
7741.JP |
J22848105 |
594 |
$76,310.93 |
2.50% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
3,999 |
$75,855.16 |
2.48% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,440 |
$73,507.94 |
2.40% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
5,216 |
$71,904.92 |
2.35% |
| Boston Scientific Corporation |
BSX |
101137107 |
916 |
$71,576.24 |
2.34% |
| Insulet Corporation |
PODD |
45784P101 |
356 |
$71,694.84 |
2.34% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
162 |
$70,957.62 |
2.32% |
| Steris Plc |
STE |
G8473T100 |
306 |
$69,657.84 |
2.28% |
| ResMed Inc. |
RMD |
761152107 |
335 |
$69,278.00 |
2.27% |
| Alcon Inc. |
ALC.SW |
H01301128 |
766 |
$68,898.40 |
2.25% |
| Revvity, Inc. |
RVTY |
714046109 |
602 |
$68,098.24 |
2.23% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
49 |
$67,761.61 |
2.22% |
| Cochlear Limited |
COH.AU |
Q25953102 |
301 |
$67,682.25 |
2.21% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
221 |
$67,067.84 |
2.19% |
| Teleflex Incorporated |
TFX |
879369106 |
291 |
$66,720.48 |
2.18% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
208 |
$65,420.16 |
2.14% |
| Danaher Corporation |
DHR |
235851102 |
260 |
$65,556.40 |
2.14% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,098 |
$64,571.35 |
2.11% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,660 |
$63,748.29 |
2.08% |
| Hologic, Inc. |
HOLX |
436440101 |
806 |
$63,238.76 |
2.07% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,867 |
$61,919.87 |
2.02% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,834 |
$61,405.64 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
265 |
$61,135.50 |
2.00% |
| Waters Corporation |
WAT |
941848103 |
193 |
$61,128.89 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
778 |
$60,761.80 |
1.99% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
482 |
$60,689.86 |
1.98% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
691 |
$60,621.43 |
1.98% |
| Stryker Corporation |
SYK |
863667101 |
182 |
$60,684.26 |
1.98% |
| Agilent Technologies, Inc. |
A |
00846U101 |
443 |
$60,274.58 |
1.97% |
| The Cooper Companies, Inc. |
COO |
216648501 |
667 |
$60,123.38 |
1.97% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,372 |
$59,883.63 |
1.96% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
108 |
$59,985.36 |
1.96% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
723 |
$59,748.72 |
1.95% |
| Abbott Laboratories |
ABT |
002824100 |
571 |
$58,653.12 |
1.92% |
| BioMerieux |
BIM.FP |
F1149Y232 |
561 |
$57,432.13 |
1.88% |
| Penumbra, Inc. |
PEN |
70975L107 |
287 |
$56,467.25 |
1.85% |
| Baxter International Inc. |
BAX |
071813109 |
1,546 |
$54,944.84 |
1.80% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
164 |
$53,974.04 |
1.77% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
501 |
$53,837.46 |
1.76% |
| DexCom, Inc. |
DXCM |
252131107 |
458 |
$53,155.48 |
1.74% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
410 |
$52,761.13 |
1.73% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
13,878 |
$50,567.72 |
1.65% |
| Masimo Corporation |
MASI |
574795100 |
452 |
$49,665.76 |
1.62% |
| Align Technology, Inc. |
ALGN |
016255101 |
198 |
$49,012.92 |
1.60% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
855 |
$42,467.85 |
1.39% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
229 |
$42,480.92 |
1.39% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
573 |
$38,919.68 |
1.27% |
| US Dollar |
$USD |
|
8,140 |
$8,140.06 |
0.27% |
| Amplifon Spa-Rts |
2452113D.IM |
|
1,867 |
$0.00 |
0.00% |
| Euro |
$EUR |
|
0 |
$0.05 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.09 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|